Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Callahan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
North Carolina Medical Journal|May 1, 1997
Health care in ancient Rome. Lessons for doctors todayR D Callahan
Annals of Internal Medicine|January 1, 1993
Eliciting patient preferencesR D Callahan
Cancer Chemotherapy and Pharmacology|January 1, 1985
Phase II trial of vincristine infusion in acute leukemiaD V Jackson, A R Chauvenet, R D Callahan, et al.
Journal of Neuro-Oncology|January 1, 1986
Clinical trial of pyridoxine to reduce vincristine neurotoxicityD V Jackson, E K Pope, R A McMahan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2018
Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancerR J Hartmaier, S E Trabucco, N Priedigkeit, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
North Carolina Medical Journal|May 1, 1997
Health care in ancient Rome. Lessons for doctors todayR D Callahan
Annals of Internal Medicine|January 1, 1993
Eliciting patient preferencesR D Callahan
Cancer Chemotherapy and Pharmacology|January 1, 1985
Phase II trial of vincristine infusion in acute leukemiaD V Jackson, A R Chauvenet, R D Callahan, et al.
Journal of Neuro-Oncology|January 1, 1986
Clinical trial of pyridoxine to reduce vincristine neurotoxicityD V Jackson, E K Pope, R A McMahan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2018
Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancerR J Hartmaier, S E Trabucco, N Priedigkeit, et al.
Pageof 1